{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:44:43Z","timestamp":1791143083211,"version":"4.1.0"},"reference-count":20,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2010,6,7]],"date-time":"2010-06-07T00:00:00Z","timestamp":1275868800000},"content-version":"vor","delay-in-days":6,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Histopathology"],"published-print":{"date-parts":[[2010,6]]},"abstract":"<jats:p>Bakarakos P, Theohari I, Nomikos A, Mylona E, Papadimitriou C, Dimopoulos A\u2010M &amp; Nakopoulou L\u2028(2010) <jats:italic>Histopathology<\/jats:italic>\u2002<jats:bold>56,<\/jats:bold> 876\u2013882\u2028<jats:bold>Immunohistochemical study of PTEN and phosphorylated mTOR proteins in familial and sporadic invasive breast carcinomas<\/jats:bold><\/jats:p><jats:p><jats:bold>Aims:\u2002<\/jats:bold> Loss of phosphatase and tensin homologue (PTEN) leads to activation of several kinases, including mammalian target of rapamycin (mTOR), which promotes cell cycle progression. The aim was to study the expression of PTEN and phosphorylated (p)\u2010mTOR in familial and sporadic invasive breast carcinomas and their relation to clinicopathological features, molecular indices (Wnt1) and patients\u2019 survival.<\/jats:p><jats:p><jats:bold>Methods and results:\u2002<\/jats:bold> PTEN and p\u2010mTOR were detected immunohistochemically in 215 sections of invasive breast carcinomas (112 with a familial history of breast cancer). Image analysis was used and univariate and multivariate analyses employed for statistical evaluation of results. PTEN was detecte5d in the nucleus (73.5%) and p\u2010mTOR in the cytoplasm (44.2%) of cancer cells. Loss of PTEN protein was more frequently detected in women with a familial history of breast cancer (72%) (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001), while its expression was negatively correlated with Wnt1, in total (<jats:italic>P<\/jats:italic>\u2003=\u20030.049). p\u2010mTOR showed a positive association with lymph node status (<jats:italic>P<\/jats:italic>\u2003=\u20030.010) and was found to have a negative impact on patients\u2019 overall survival (<jats:italic>P<\/jats:italic>\u2003= 0.016).<\/jats:p><jats:p><jats:bold>Conclusions:\u2002<\/jats:bold> Loss of PTEN protein expression appears to occur more frequently in women with a family history of breast cancer, whereas activation of mTOR protein seems to be related to a more aggressive phenotype.<\/jats:p>","DOI":"10.1111\/j.1365-2559.2010.03570.x","type":"journal-article","created":{"date-parts":[[2010,6,7]],"date-time":"2010-06-07T21:03:34Z","timestamp":1275944614000},"page":"876-882","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Immunohistochemical study of PTEN and phosphorylated mTOR proteins in familial and sporadic invasive breast carcinomas"],"prefix":"10.1111","volume":"56","author":[{"given":"Panagiotis","family":"Bakarakos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Theohari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Nomikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Mylona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Papadimitriou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios\u2010Meletios","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Nakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2010,6,7]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2005.11.042"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2005.06.007"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M309999200"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12779-1"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2004.05.029"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2204"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/humu.10257"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0112"},{"key":"e_1_2_7_10_2","first-page":"25","article-title":"Comparing the prognostic value of PTEN and Akt expression with the mitotic activity index in adjuvant chemotherapy\u2010treated node\u2010negative breast cancer patients aged <55 years","volume":"29","author":"Janssen EA","year":"2007","journal-title":"Cell Oncol."},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1471-4892(03)00071-7"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.008599"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1500.1999.99035.x"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-006-9012-6"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2007.64"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0181"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1611"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800525"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1609"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00129039-200409000-00004"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-05-0896"}],"container-title":["Histopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2559.2010.03570.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2559.2010.03570.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T07:05:54Z","timestamp":1698649554000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2559.2010.03570.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["10.1111\/j.1365-2559.2010.03570.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2559.2010.03570.x","archive":["Portico"],"relation":{},"ISSN":["0309-0167","1365-2559"],"issn-type":[{"value":"0309-0167","type":"print"},{"value":"1365-2559","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"2010-06-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}